NextCure
NXTC
82 hedge funds and large institutions have $749M invested in NextCure in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 15 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 25
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.01% less ownership
Funds ownership: 6.13% → 6.12% (-0.01%)
7% less funds holding
Funds holding: 88 → 82 (-6)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
34% less capital invested
Capital invested by funds: $1.14B → $749M (-$388M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$30.9M |
| 2 |
Jennison Associates
New York
|
+$16.2M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$8.49M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$7.94M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$3.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$31.8M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$11.4M |
| 3 |
CPX
Canaan Partners X
Menlo Park,
California
|
-$10.1M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$8.45M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$5.24M |
NXTC Hedge Fund Activity: Q1 2020 in Review
82 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q1 2020, worth a combined $749M — down 34% from $1.14B a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of NXTC and 11 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 30 added.
The largest buyer was Lord, Abbett & Co, adding an estimated $30.9M. The largest seller was Citadel Advisors, cutting an estimated $31.8M.
- 82 institutional investors held NextCure (NXTC) as of Q1 2020, down from 88 in Q4 2019.
- Funds reported $749M of NextCure stock for Q1 2020, down 34% quarter-over-quarter.
- 11 funds opened new NextCure positions in Q1 2020 and 15 closed out, a net change of -4 holders.
- The largest NextCure buyer in Q1 2020 was Lord, Abbett & Co, an estimated $30.9M added.
- The largest NextCure seller in Q1 2020 was Citadel Advisors, an estimated $31.8M sold.
Based on aggregated 13F filings for Q1 2020.